These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17576164)

  • 21. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats.
    Hock JM; Fonseca J; Gunness-Hey M; Kemp BE; Martin TJ
    Endocrinology; 1989 Oct; 125(4):2022-7. PubMed ID: 2791976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.
    Yang Y; Aghazadeh-Habashi A; Panahifar A; Wu Y; Bhandari KH; Doschak MR
    Drug Deliv Transl Res; 2017 Aug; 7(4):482-496. PubMed ID: 28721611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
    von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
    J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion.
    Fox J; Miller MA; Stroup GB; Nemeth EF; Miller SC
    Bone; 1997 Aug; 21(2):163-9. PubMed ID: 9267692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of hPTHrP (1-36) as an anabolic therapeutic agent for osteoporosis].
    Takeuchi Y
    Clin Calcium; 2011 Jan; 21(1):28-32. PubMed ID: 21187591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
    Qi H; Li M; Wronski TJ
    J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.
    Pierroz DD; Bonnet N; Baldock PA; Ominsky MS; Stolina M; Kostenuik PJ; Ferrari SL
    J Biol Chem; 2010 Sep; 285(36):28164-73. PubMed ID: 20558734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous PTH and endogenous 1,25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone.
    Samadfam R; Xia Q; Miao D; Hendy GN; Goltzman D
    J Bone Miner Res; 2008 Aug; 23(8):1257-66. PubMed ID: 18348699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of parathyroid hormone on bone metabolism : differences between intermittent and continuous treatment].
    Ishizuya T
    Clin Calcium; 2012 Mar; 22(3):357-63. PubMed ID: 22370302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.
    Ferrari SL; Pierroz DD; Glatt V; Goddard DS; Bianchi EN; Lin FT; Manen D; Bouxsein ML
    Endocrinology; 2005 Apr; 146(4):1854-62. PubMed ID: 15705780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone anabolic effects of PTH(1-34) and salmon calcitonin in ovariectomy- and ovariectomy-steroid-induced osteopenic rats: a histomorphometric and biomechanical study.
    Fukushima T; Nitta T; Furuichi H; Izumo N; Fukuyama T; Nakamuta H; Koida M
    Jpn J Pharmacol; 2000 Mar; 82(3):240-6. PubMed ID: 10887955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
    Hock JM; Gera I; Fonseca J; Raisz LG
    Endocrinology; 1988 Jun; 122(6):2899-904. PubMed ID: 3371266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice.
    Samadfam R; Xia Q; Goltzman D
    J Bone Miner Res; 2007 Jan; 22(1):55-63. PubMed ID: 17014384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone.
    Turner RT; Lotinun S; Hefferan TE; Morey-Holton E
    J Appl Physiol (1985); 2006 Sep; 101(3):881-6. PubMed ID: 16675609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
    van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
    Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.